FdaApplication

ANDA 218427

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAPOTEX INC
application_typeANDA
approval_date2026-03-02

Products (1)

ProductActive ingredientStrengthDosage form
RIVAROXABANRIVAROXABAN1MG/MLFOR SUSPENSION;ORAL

1 product